TFF Pharmaceuticals (TFFP) Analyst Estimates Annual - Discounting Cash Flows
TFF Pharmaceuticals, Inc.
TFFP (NASDAQ)

* (except for per share items) of USD
Period Ending: 2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
Number of Analysts 1 1 1 1 1 1 1 1 1
Estimated Revenue
Low 98.3 62.2 11.7 0.80 1.15 0.70 0.21 0.68 0.33
Average 98.3 62.2 11.7 0.80 1.15 0.70 0.21 0.68 0.33
High 98.3 62.2 11.7 0.80 1.15 0.70 0.21 0.68 0.33
Estimated EBITDA
Low 59.0 37.3 7.04 0.48 0.69 0.42 0.13 0.41 0.20
Average 59.0 37.3 7.04 0.48 0.69 0.42 0.13 0.41 0.20
High 59.0 37.3 7.04 0.48 0.69 0.42 0.13 0.41 0.20
Estimated EBIT
Low 59.0 37.3 7.04 0.48 0.69 0.42 0.13 0.41 0.20
Average 59.0 37.3 7.04 0.48 0.69 0.42 0.13 0.41 0.20
High 59.0 37.3 7.04 0.48 0.69 0.42 0.13 0.41 0.20
Estimated Net Income
Low 7.17 -1.65 -4.86 -6.76 -7.67 -21.5 -53.3 -50.5 -38.8
Average 7.17 -1.65 -4.86 -6.76 -7.67 -21.5 -53.3 -50.5 -38.8
High 7.17 -1.65 -4.86 -6.76 -7.67 -21.5 -53.3 -50.5 -38.8
Estimated SGA Expenses
Low 362 229 43.2 2.94 4.24 2.58 0.78 2.49 1.23
Average 362 229 43.2 2.94 4.24 2.58 0.78 2.49 1.23
High 362 229 43.2 2.94 4.24 2.58 0.78 2.49 1.23
Estimated EPS
Low 4.000 -0.920 -2.710 -3.770 -4.280 -12.00 -29.75 -28.17 -21.62
Average 4.000 -0.920 -2.710 -3.770 -4.280 -12.00 -29.75 -28.17 -21.62
High 4.000 -0.920 -2.710 -3.770 -4.280 -12.00 -29.75 -28.17 -21.62
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us